*3.15.3 SCD-1 inhibitors*

Stearoyl-CoA Desaturase-1 (SCD-1) transforms saturated fatty acids into monounsaturated fatty acids and is widely expressed in adipose tissue and the liver. In NAFLD patients, it is quite active. This inhibition leads to reduced steatosis and improvement of insulin sensitivity [42].
